15.06.2017@http://ijrdpl.com http://dx.doi.org/10.21276/IJRDPL.227 8-0238.2017.6(4). [2726][2727][2728][2729][2730][2731] ABSTRACT:This study is mainly focused on the ability of polymer to increase the bioavailability of Furosemide and to release the drug in controlled predetermined manner. The polymers selected for the study include natural and synthetic polymer like Chitosan and sodium HPMC based on their physicochemical properties. The mucoadhesive buccal patches were prepared by solvent casting method. The prepared patches were subjected to physical evaluations, in vitro diffusion studies and stability study. All the formulations have shown good adhesive property, tensile strength, folding endurance, thickness, pH and moisture content. The diffusion studies have shown that the percentage drug release is from natural polymer (chitosan) based patches is more than the synthetic polymer (sodium HPMC) (89.5% to 97.89%) with chitosan based mucoadhesive patches and 72.97 to 88.75 patches prepared with sodium HPMC in 6 hours. The In vitro drug release, evaluation, stability and accelerated stability studies of the mucoadhesive patches shown that the formulation containing natural polymer 2% has the promising results with 97.89% drug release within 6 hours, folding endurance 211+2, patch thickness 0.7mm, surface pH 6.7, % swelling index 36% moisture content 3.3,tensile strength 2.94+3kg/cm 2 . ⇑ Corresponding author at:
INTRODUCTION
Buccal delivery is considered to be a major alternative to the oral and buccal routes of systemic drug delivery. The buccal mucosa provides readily accessible route for Trans-mucosal delivery. Absorption through the buccal mucosa overcomes premature drug degradation due to the enzyme activity and pH of gastro intestinal tract, avoids active drug loss due to presystemic metabolism, acid hydrolysis and therapeutic plasma concentration of the drug can be rapidly achieved. The adhesive properties of such drug delivery platforms can reduce the enzymatic degradation due to the increased intimacy between the delivery vehicle and the absorbing membrane. It has also been used as a pharmaceutical excipient in conventional dosage forms as well as in novel applications involving bio adhesion and trans mucosal drug transport [1] .
The average development cost of a new chemical entity (NCE) is approximately $150-350 million. It often costs substantially less to develop new methods of administration for an existing drug, which results in improved efficacy and bioavailability together with reduced dosing frequency to minimize side effects. Therefore, pharmaceutical companies are under constant pressure to maximize the full potential of a drug candidate. This objective can be accomplished by incorporating the drug into various drug delivery systems. This exercise can lead to convenient dosage forms that overcome previously presented administration problems. For the last two decades, there has been an enhanced demand for more patient-compliant dosage forms [2] [3] .
Ideal attributes of a drug delivery system[4]
 Capable in precise control of constant drug delivery rate.
 Capable of controlled delivery rates to accommodate the pharmacokinetics of various drugs.
 Applicable to a wide range and varieties of drug.
 Should not have any effect on drug stability.
 Capable of high order of drug dispersion.
 Since the early 1980s there has been renewed interest in the use of bioadhesive polymers to prolong contact INTRODUCTION Buccal delivery is considered to be a major alternative to the oral and buccal routes of systemic drug delivery. The buccal mucosa provides readily accessible route for Trans-mucosal delivery. Absorption through the buccal mucosa overcomes premature drug degradation due to the enzyme activity and pH of gastro intestinal tract, avoids active drug loss due to presystemic metabolism, acid hydrolysis and therapeutic plasma concentration of the drug can be rapidly achieved. The adhesive properties of such drug delivery platforms can reduce the enzymatic degradation due to the increased intimacy between the delivery vehicle and the absorbing membrane. It has also been used as a pharmaceutical excipient in conventional dosage forms as well as in novel applications involving bio adhesion and trans mucosal drug transport [1] . 
 Should not have any effect on drug stability. time in the various mucosal routes of drug administration. The ability to maintain a delivery system at a particular location for an extended period of time has great appeal for both local as well as systemic drug bioavailability. Drug absorption through a mucosal surface is efficient because mucosal surfaces are usually rich in blood supply, providing rapid drug transport to the systemic circulation and avoiding degradation by gastrointestinal enzymes and first pass hepatic metabolism.
Oral Transmucosal Drug Delivery[5]
via mucous membranes of the oral cavity was noted as early as 1847 by Sobvero, the discovery of nitroglycerin, and systemic studies of oral cavity absorption was first reported by Walton in Within the oral cavity delivery of drug is classified into several categories. Absorption of drug 1935. Due to its excellent accessibility and reasonable patient compliance oral mucosal cavity offers attractive route of drug administration. Within the oral mucosal cavity delivery of drug is classified into three categories:
 Sublingual delivery, which is a systemic delivery of drug through the mucosal membrane lining the floor of the mouth  Buccal delivery&Local delivery, for the treatment of conditions of the oral cavity. The oral cavity is foremost part of digestive system of human body. It is also referred to as "buccal cavity". It is accountable for various primary functions of body. The careful examination of various features of oral cavity can help in development of a suitable Bucco adhesive drug delivery system.
Oral Cavity[6]
Components and structural features of oral cavity:
Oral cavity is that area of mouth which is delineated or surrounded by lips, cheeks, hard palate, soft palate and floor of mouth. The oral cavity consists of two regions, Outer oral vestibule, which is bounded by cheeks, lips, teeth and gingival (Gums) and Oral cavity proper, which extends from teeth and gums back to the feces (which lead to pharynx) with the roof comprising the hard and soft palate. The tongue projects from the floor of the cavity. A detailed outline of buccal cavity is being given in Fig.1 .
Fig. 1: A detailed outline of buccal cavity
Anatomical Features [7, 8] The outer surface of the oral cavity is a mucous membrane consisting of an epithelium, basement membrane and lamina propria overlying a submucousa containing blood vessels and nerves. The mucosa can be divided into three types: Masticatory mucosa, found on the gingiva and hard palate. Lining mucosa, found on the lips, cheeks, floor of mouth, undersurface of the tongue and the soft palate. Specialized mucosa found on the upper surface of the tongue and parts of the lips. All consists of a squamous stratified epithelium, many cell layers (40-50 for buccal mucosa) overlying a connective tissue, layer, the lamina propria. The total surface area of oral cavity= 170 cm².
Animals
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SUMMARY AND CONCLUSION
The study presents a good approach to increase the bioavailability of the poorly bio available drug and its release in a controlled manner. Some drugs have wide therapeutics use for the treatment of various diseases but sometimes, their oral does not produce therapeutic effects because of their poor bioavailability. Oral dosage forms are most widely used because of the advantages over parental dosage form like patient compliance, cheap, having less side effects etc. The drug selected for incorporation in the mucoadhesive buccal patch. Though oral route is considered as safest route of drug administration, but pre-systemic metabolism of the drug is the main disadvantage, which results in the incomplete availability of drug in systemic circulation. An alternative approach is buccal drug delivery which provides prolonged and sustained drug release through buccal mucosa.
In the present investigation matrix type buccal patches Furosemide, Polymer hydroxypropylemethylcellulose, (Chitosan) & glycerol as both plasticizer and penetration enhancer were developed and evaluated for the precise delivery of drug penetration across the buccal mucosa.
Wide range of approaches in the design and implementation of buccal drug delivery system including prolonged release patch preparation, mucoadhesion, in-vitro penetration and release profile, in-vivo studies, biocompatibility, toxicity studies etc have been critically examined.
Matrix system based Buccal patches of Furosemide were prepared of Glycerol as both plasticizer and penetration enhancer.
The result of present investigation stated that HPMC and chitosan have good matrix/film forming characteristics which was confirmed by the visual and physiological characterization of the patches. The in-vitro and ex-vivo studies indicated that successful buccal patches of Furosemide could be prepared using hydrophilic polymers viz. Chitosan employing solvent casting technique. It was found during investigation that as the concentration of chitosan was increased the release rate also inclined and the patches showed lesser mucoadhesion time while on the other hand as the concentration of Chitosan was increased the drug release was found to be controlled and the patch also reflected sufficient mucoadhesion time period.
Buccal delivery is a major alternative to the oral and parenteral routes of systemic drug delivery. The buccal mucosa provides readily accessible route for Buccalmucosal delivery. Absorption through the buccal mucosa overcomes premature drug degradation due to the enzyme activity and pH of gastro intestinal tract, avoids active drug loss due to pre-systemic metabolism, acid hydrolysis and therapeutic plasma concentration of the drug can be rapidly achieved. The adhesive properties of such drug delivery platforms can reduce the enzymatic degradation due to the increased intimacy between the delivery vehicle and the absorbing membrane. It has also been used as a pharmaceutical excipient in conventional dosage forms as well as in novel applications involving bioadhesion and buccalmucosal drug transport.
It has been found that oral controlled release dosage forms are not suitable for variety of important drugs characterized by the incomplete availability of drug in systemic circulation.
However, the success of a drug to be used for systemic delivery via buccal route depends mainly on the ability of the drug to permeate through buccal mucosa in sufficient quantities which
